RE

RBC Europe Portfolio holdings

AUM $2.08B
This Quarter Return
+5.09%
1 Year Return
-12.2%
3 Year Return
+59.81%
5 Year Return
+127.2%
10 Year Return
AUM
$762M
AUM Growth
Cap. Flow
+$762M
Cap. Flow %
100%
Top 10 Hldgs %
35.68%
Holding
1,138
New
1,138
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Financials 21.65%
2 Technology 13.88%
3 Consumer Discretionary 12.96%
4 Communication Services 12.75%
5 Healthcare 11.16%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GENE
1126
DELISTED
Genetic Technologies Ltd.
GENE
$68 ﹤0.01% +80 New +$68
GCVRZ
1127
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$47 ﹤0.01% +130 New +$47
GRCE
1128
Grace Therapeutics, Inc. Common Stock
GRCE
$41.9M
$43 ﹤0.01% +30 New +$43
LSTA icon
1129
Lisata Therapeutics
LSTA
$19.9M
$36 ﹤0.01% +10 New +$36
OIBR.C
1130
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$31 ﹤0.01% +4 New +$31
CDTI
1131
DELISTED
CDTI Advanced Materials, Inc. Common Stock
CDTI
$22 ﹤0.01% +13 New +$22
PALI icon
1132
Palisade Bio
PALI
$6.3M
$21 ﹤0.01% +16 New +$21
DRIO icon
1133
DarioHealth
DRIO
$22.8M
$11 ﹤0.01% +6 New +$11
APEN
1134
DELISTED
Apollo Endosurgery, Inc.
APEN
$5 ﹤0.01% +1 New +$5
MBOT icon
1135
Microbot Medical
MBOT
$185M
$4 ﹤0.01% +3 New +$4
NUWE icon
1136
Nuwellis
NUWE
$4.6M
$2 ﹤0.01% +3 New +$2
IMUC
1137
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$1 ﹤0.01% +2 New +$1